News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
News|Slideshows|June 30, 2025

June Pharmaceutical Industry Movers & Shakers

Author(s)Don Tracy, Associate Editor

A monthly roundup of business and people news in the pharmaceutical industry.

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com fda approval

FDA Approves Foundayo Under National Priority Voucher Program

ByNicholas Jacobus
April 1st 2026
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul

ByNicholas Jacobus
April 1st 2026
Christopher Locher

Being Specific About Being General: Vaccines Edition

ByChris Spivey,Christopher Locher, PhD
April 1st 2026
Stock.adobe.com

Trump Administration Delays Appeal of Vaccine Ruling as Political Pressures Mount Ahead of Midterms: Report

ByNicholas Jacobus
April 1st 2026
Stock.adobe.com

Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals

ByNicholas Jacobus
April 1st 2026
Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Foundayo Under National Priority Voucher Program

2

Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals

3

Merck Enters $838 Million Research & Development Collaboration with Infinimmune

4

Novo Nordisk Launches Multi-Month Subscription Program for Wegovy

5

What Potential Fallout Will MFN Policies Have?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us